Director, Global Medical Content and Training
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
Reporting to the Head of Medical Content and Training, the Director Medical Content and Training will be responsible for shaping the Medical Affairs training and content roadmap in alignment with therapeutic area strategies and launch priorities. This role will play a critical role in preparing the team for product launches in oncology, ensuring they are equipped with the necessary knowledge and materials to communicate scientific data effectively.
This role will help ensure that the Medical Science
